For the first time in over 10,000 years, the howl of a dire wolf is echoing once more—this time, from within a secretive ...

Call them dire wolves. Don’t call them dire wolves. Colossal Biosciences, the biotechnology company from Dallas, Texas, that wants to de-extinct the woolly mammoth and dodo, doesn’t care what you call ...

There was a similar theme in the online responses to the author of 'Game of Thrones' encounter with the wolves.

The headlines and TV chyrons delivered the breathless news: The dire wolves had returned. It was kind of thrilling, even if you were not a fan of “Game of Thrones” where the creatures were a baleful ...

So, Colossal Biosciences — the company that’s somehow worth a casual $10.2 billion without delivering any real de-extinction success — announced they’ve “brought back” the dire wolf. A slow clap from ...

Biotechnology company Colossal Biosciences used genetic editing techniques to alter 20 genes of gray wolves (pictured above) to express certain characteristics of ancient dire wolves. The company says ...

When Colossal Laboratories and Biosciences' announced it was bringing back dire wolves from extinction, lots of people wondered if this was fact or fantasy. William Lynn, a research scientist at Clark ...

The industry’s pawprints are all over the buzzy de-extincted canine, with famous investors including Peter Jackson and George R.R. Martin. But was it all for show? By Degen Pener Deputy Editor ...

The treatment targets and stops production of abnormal huntingtin proteins responsible for disease progression. Delivered ...